FDC gets USFDA nod for Ofloxacin Otic Solution
Mumbai: Pharma firm FDC Limited has recently announced that the company has received approval from the United States Food and Drug Administration (USFDA) for Ofloxacin Otic Solution, 0.3%."This is to inform you that, the Company has been granted ANDA approval by USFDA, for Ofloxacin Otic Solution, 0.3%," the company said in a BSE filing.An abbreviated new drug application contains data which...
Mumbai: Pharma firm FDC Limited has recently announced that the company has received approval from the United States Food and Drug Administration (USFDA) for Ofloxacin Otic Solution, 0.3%.
"This is to inform you that, the Company has been granted ANDA approval by USFDA, for Ofloxacin Otic Solution, 0.3%," the company said in a BSE filing.
An abbreviated new drug application contains data which is submitted to FDA for the review and potential approval of a generic drug product. Once approved, an applicant may manufacture and market the generic drug product to provide a safe, effective, lower cost alternative to the brand-name drug it references.
Read also: Covid-19: FDC launches first Favipiravir Oral Suspension Favenza in India
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd